{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T08:55:16Z","timestamp":1790326516147,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.jval.2012.07.007","type":"journal-article","created":{"date-parts":[[2012,11,3]],"date-time":"2012-11-03T20:30:47Z","timestamp":1351974647000},"page":"1084-1091","source":"Crossref","is-referenced-by-count":32,"title":["Using the Multiple Sclerosis Impact Scale to Estimate Health State Utility Values: Mapping from the MSIS-29, Version 2, to the EQ-5D and the SF-6D"],"prefix":"10.1016","volume":"15","author":[{"given":"Annie","family":"Hawton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Telford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Zajicek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dave","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jval.2012.07.007_bib1","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.jval.2012.07.007_bib2","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1136\/jnnp.2008.171181","article-title":"Responsiveness of patient reported outcome measures in multiple sclerosis relapses: the REMS study","volume":"80","author":"Giordano","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jval.2012.07.007_bib3","unstructured":"US Department of Health and Human Services, Food and Drug Administration. Guidance for Industry. Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. Silver Spring, USA: US Department of Health and Human Services Food and Drug Administration, 2009."},{"key":"10.1016\/j.jval.2012.07.007_bib4","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1212\/WNL.0b013e3181dbb884","article-title":"Patient-centred outcomes: translating clinical efficacy into benefits on health-related quality of life","volume":"74","author":"Miller","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.jval.2012.07.007_bib5","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1177\/1352458509106513","article-title":"The development of patient-reported outcome indices for multiple sclerosis (PRIMUS)","volume":"15","author":"Doward","year":"2009","journal-title":"Multiple Sclerosis"},{"key":"10.1016\/j.jval.2012.07.007_bib6","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/brain\/124.5.962","article-title":"The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure","volume":"124","author":"Hobart","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.jval.2012.07.007_bib7","doi-asserted-by":"crossref","unstructured":"Hobart J, Cano S. Improving the evaluation of therapeutic interventions in multiple sclerosis: the role of new psychometric methods. Health Technol Assess 2009;13:1-216.","DOI":"10.3310\/hta13120"},{"key":"10.1016\/j.jval.2012.07.007_bib8","first-page":"266","article-title":"The Multiple Sclerosis Impact Scale (MSIS-29) is a reliable and sensitive measure","volume":"75","author":"McGuigan","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jval.2012.07.007_bib9","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1477-7525-7-58","article-title":"Rasch analysis of the Multiple Sclerosis Impact Scale (MSIS-29)","volume":"7","author":"Ramp","year":"2009","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.jval.2012.07.007_bib10","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1136\/jnnp.73.6.701","article-title":"Multiple Sclerosis Impact Scale (MSIS-29): reliability and validity in hospital samples","volume":"73","author":"Riazi","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jval.2012.07.007_bib11","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1136\/jnnp.2005.065227","article-title":"Psychometric evaluation of the Multiple Sclerosis Impact Scale (MSIS-29) for proxy use","volume":"76","author":"van der Linden","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jval.2012.07.007_bib12","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1136\/jnnp.2006.105759","article-title":"The patient know best: significant change in the physical component of the Multiple Sclerosis Impact Scale (MSIS-29 physical)","volume":"78","author":"Costelloe","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jval.2012.07.007_bib13","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1136\/jnnp.2005.064584","article-title":"How responsive is the Multiple Sclerosis Impact Scale (MSIS-29)? A comparison with some other self-report scales","volume":"76","author":"Hobart","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jval.2012.07.007_bib14","series-title":"Cost-Effectiveness in Health and Medicine","author":"Gold","year":"1996"},{"key":"10.1016\/j.jval.2012.07.007_bib15","series-title":"Measuring and Valuing Health Benefits for Economic Evaluation","author":"Brazier","year":"2007"},{"key":"10.1016\/j.jval.2012.07.007_bib16","unstructured":"National Institute for Health and Clinical Excellence. Guide to the Methods of Technology Appraisal. London: National Institute for Health and Clinical Excellence, 2008."},{"key":"10.1016\/j.jval.2012.07.007_bib17","series-title":"Guidelines for Preparing Submissions to the Pharmaceutical Benefits Advisory Committee (Version 4.3)","author":"Pharmaceutical Benefits Advisory Committee","year":"2008"},{"key":"10.1016\/j.jval.2012.07.007_bib18","unstructured":"Guidelines for the Economic Evaluation of Health Technologies (3rd ed.). Ottawa, Canada: Canadian Agency for Drugs and Technologies in Health, 2006."},{"key":"10.1016\/j.jval.2012.07.007_bib19","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10198-009-0168-z","article-title":"A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures","volume":"11","author":"Brazier","year":"2010","journal-title":"Eur J Health Econ"},{"key":"10.1016\/j.jval.2012.07.007_bib20","series-title":"EQ-5D User Guide","author":"EuroQol Group","year":"1996"},{"key":"10.1016\/j.jval.2012.07.007_bib21","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/00005650-199711000-00002","article-title":"Modeling valuations for EuroQol health states","volume":"35","author":"Dolan","year":"1997","journal-title":"Med Care"},{"key":"10.1016\/j.jval.2012.07.007_bib22","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0167-6296(01)00130-8","article-title":"The estimation of a preference-based single index measure for health from the SF-36","volume":"21","author":"Brazier","year":"2002","journal-title":"J Health Econ"},{"key":"10.1016\/j.jval.2012.07.007_bib23","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/01.mlr.0000135827.18610.0d","article-title":"The estimation of a preference-based measure of health from the SF-12","volume":"42","author":"Brazier","year":"2004","journal-title":"Med Care"},{"key":"10.1016\/j.jval.2012.07.007_bib24","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/j.1524-4733.2010.00770.x","article-title":"Use of a disease-specific instrument in economic evaluations: mapping WOMAC onto the EQ-5D utility index","volume":"8","author":"Xie","year":"2010","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2012.07.007_bib25","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s10198-010-0233-7","article-title":"Mapping the QLQ-C30 quality of life cancer to EQ-5D patient preferences","volume":"11","author":"Crott","year":"2010","journal-title":"Eur J Health Econ"},{"key":"10.1016\/j.jval.2012.07.007_bib26","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1524-4733.2007.00171.x","article-title":"Mapping from disease-specific measures to utility: an analysis of the relationship between the Inflammatory Bowel Disease Questionnaire and Crohn's Disease Activity Index in Crohn's disease and measures of utility","volume":"10","author":"Buxton","year":"2007","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2012.07.007_bib27","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1472-6963-6-96","article-title":"Mapping oral health related quality of life to generic health state values","volume":"6","author":"Brennan","year":"2006","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.jval.2012.07.007_bib28","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/bmj.326.7388.522","article-title":"Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosis","volume":"326","author":"Chilcott","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.jval.2012.07.007_bib29","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1471-2377-10-88","article-title":"Patient-orientated longitudinal study of multiple sclerosis in south west England (The South West Impact of Multiple Sclerosis Project, SWIMS), 1: protocol and baseline characteristics of cohort","volume":"10","author":"Zajicek","year":"2010","journal-title":"BMC Neurol"},{"key":"10.1016\/j.jval.2012.07.007_bib30","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11136-009-9558-z","article-title":"Mapping analyses to estimate health utilities based on responses to the OM8-30 otitis media questionnaire","volume":"19","author":"Dakin","year":"2010","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jval.2012.07.007_bib31","series-title":"Review of Methods for Mapping between Measures of Health Related Quality of Life Onto Generic Preference-Based Measures: A Road to Nowhere?","author":"Brazier","year":"2007"},{"key":"10.1016\/j.jval.2012.07.007_bib32","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/j.1524-4733.2008.00352.x","article-title":"Deriving an algorithm to convert the eight mean SF-36 dimensions scores into a mean EQ-5D preference-based score from published studies (where patient level data are not available)","volume":"11","author":"Ara","year":"2008","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2012.07.007_bib33","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1477-7525-6-51","article-title":"Do estimates of cost-utility based on the EQ-5D differ from those based on the mapping of utility scores?","volume":"6","author":"Barton","year":"2008","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.jval.2012.07.007_bib34","series-title":"Regression Models for Categorical and Limited Dependent Variables","author":"Long","year":"1997"},{"key":"10.1016\/j.jval.2012.07.007_bib35","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0304-4076(84)90004-6","article-title":"Least absolute deviations estimation for the censored regression model","volume":"25","author":"Powell","year":"1984","journal-title":"J Econometrics"},{"key":"10.1016\/j.jval.2012.07.007_bib36","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/0272989X06290496","article-title":"Mapping the EQ-5D index from the SF-12: US general population preferences in a nationally representative sample","volume":"26","author":"Sullivan","year":"2006","journal-title":"Med Decision Making"},{"key":"10.1016\/j.jval.2012.07.007_bib37","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1472-6963-6-96","article-title":"Mapping oral health related quality of life to generic health state values","volume":"6","author":"Brennan","year":"2006","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.jval.2012.07.007_bib38","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/hec.866","article-title":"A comparison of the EQ-5D and SF-6D across seven patient groups","volume":"13","author":"Brazier","year":"2004","journal-title":"Health Econ"},{"key":"10.1016\/j.jval.2012.07.007_bib39","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10198-008-0097-2","article-title":"SF-6D versus EQ-5D: reasons for differences in utility scores and impact on reported cost-utility","volume":"10","author":"Grieve","year":"2008","journal-title":"Eur J Health Econ"},{"key":"10.1016\/j.jval.2012.07.007_bib40","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1477-7525-7-27","article-title":"Mapping SF-36 onto the EQ-5D index: how reliable is the relationship?","volume":"7","author":"Rowen","year":"2009","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.jval.2012.07.007_bib41","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s11136-008-9392-8","article-title":"Mapping the eight-item Parkinson's Disease Questionnaire (PDQ-8) to the EQ-5D utility index","volume":"17","author":"Cheung","year":"2008","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jval.2012.07.007_bib42","series-title":"Relationship between the EuroQol-5D and Barthel Index\u2014Examining the Use of Proxy Outcome Measures for Older People","author":"Kaambwa","year":"2006"},{"key":"10.1016\/j.jval.2012.07.007_bib43","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1477-7525-7-27","article-title":"Mapping SF-36 onto the EQ-5D index: how reliable is the relationship?","volume":"7","author":"Rowen","year":"2009","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.jval.2012.07.007_bib44","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1177\/0272989X11427761","article-title":"Mapping QLQ-C30, HAQ, and MSIS-29 on EQ-5D.","volume":"32","author":"Versteegh","year":"2012","journal-title":"Medical Decision Making"},{"key":"10.1016\/j.jval.2012.07.007_bib45","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/j.1524-4733.2009.00569.x","article-title":"Mapping the cancer-specific EORTC QLQ-C30 to the preference-based EQ-5D, SF-6D and 15D instruments","volume":"12","author":"Kontodimopoulos","year":"2009","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2012.07.007_bib46","series-title":"Capturing Information Loss in Estimates of Uncertainty that Arise from Mapping Algorithms","author":"Round","year":"2008"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301512017068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301512017068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T02:49:59Z","timestamp":1562294999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301512017068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S1098301512017068"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2012.07.007","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}